Kenneth T. Mills
2019
In 2019, Kenneth T. Mills earned a total compensation of $6.1M as President and CEO at Regenxbio, a 24% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $375,188 |
|---|---|
| Option Awards | $5,160,444 |
| Salary | $595,537 |
| Other | $16,100 |
| Total | $6,147,269 |
Mills received $5.2M in option awards, accounting for 84% of the total pay in 2019.
Mills also received $375.2K in non-equity incentive plan, $595.5K in salary and $16.1K in other compensation.
Rankings
In 2019, Kenneth T. Mills' compensation ranked 1,646th out of 13,971 executives tracked by ExecPay. In other words, Mills earned more than 88.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,646 out of 13,971 | 88th |
Division Manufacturing | 588 out of 5,695 | 90th |
Major group Chemicals And Allied Products | 177 out of 2,194 | 92nd |
Industry group Drugs | 143 out of 1,880 | 92nd |
Industry Biological Products, Except Diagnostic Substances | 32 out of 389 | 92nd |
Source: SEC filing on April 7, 2022.
Mills' colleagues
We found four more compensation records of executives who worked with Kenneth T. Mills at Regenxbio in 2019.